Premier Alternatives

Duo Oncology

Pittsburgh, PA · Founded 2020 · Privately Held (backing)

Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. Duo Oncology is based in Pittsburgh, PA and was founded in 2020. It was valued at $25 million at its seed round in Jun 2025, the last priced event on record. It has raised $13.1 million across 3 recorded rounds; the latest was a $1.4 million seed round in Jun 2025.

PMV mark · valuation
$25.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$13.1M
Last round
Seed Round
Jun 2025

Who backs Duo Oncology?

10 investors
InvestorType
Innovation WorksVenture capital
Ulu VenturesVenture capital
SeedFolioVenture capital
BeOne Medicines—
LifeX Ventures—
National Cancer Institute I-Corps—
NuFund Venture Group—
Prevail Partners—
U.S. Department of Health and Human Services—
University of Pittsburgh Innovation Institute—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Duo Oncology investors

10 investors are on record for Duo Oncology, including Innovation Works, Ulu Ventures, SeedFolio and BeOne Medicines. The seed round in Jun 2025 drew 13 investors.

Free account
More of Duo Oncology with a free account
  • ·Watch Duo Oncology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Duo Oncology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View